The suprabasal expression of alpha 6 beta 4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis - PubMed (original) (raw)

. 1993 Oct 15;53(20):4803-10.

Affiliations

PMID: 8402665

The suprabasal expression of alpha 6 beta 4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis

T Tennenbaum et al. Cancer Res. 1993.

Abstract

Enhanced expression of the alpha 6 beta 4 integrin complex has been linked to malignant progression in mouse skin carcinogenesis. To determine if alpha 6 beta 4 expression can predict risk for malignant conversion among populations of benign skin tumors, we analyzed the distribution of alpha 6 beta 4 and other markers of progression in papillomas at high and low risk for malignant progression. After initiation with 7,12-dimethylbenz[a]anthracene, mice were promoted with 12-O-tetradecanoylphorbol-13-acetate to induce predominantly low risk tumors or promoted with mezerein to produce predominantly high risk tumors. When tumors first appeared at 8 weeks after promotion, high risk papillomas demonstrated basal and suprabasal alpha 6 beta 4 expression, loss of keratin 1, and aberrant expression of keratin 13. In these tumors alpha 6 beta 4 expression coincided with an expansion of the proliferating compartment as indicated by suprabasal bromodeoxyuridine labeling. In contrast, alpha 6 beta 4 immunostaining was confined to basal cells in low risk tumors, keratin 1 was abundant, and keratin 13 was absent in the majority of this group, while proliferating cells were largely in the basal compartment. By 33 weeks, alpha 6 beta 4 suprabasal expression continued to distinguish groups at higher risk for malignant conversion, but keratin 13 was expressed in all groups. At this time, high risk tumors displayed focal expression of keratin 8 and gamma-glutamyltranspeptidase, markers also found in chemically induced carcinomas. Keratin 8 and gamma-glutamyltranspeptidase were expressed only in alpha 6 beta 4 positive cells. These results indicate that expression of alpha 6 beta 4 integrin in suprabasal strata serves as an early predictive marker to identify benign squamous tumors at high risk for malignant progression.

PubMed Disclaimer

Cited by

The Cohesive Metastasis Phenotype in Human Prostate Cancer.
Harryman WL, Hinton JP, Rubenstein CP, Singh P, Nagle RB, Parker SJ, Knudsen BS, Cress AE. Harryman WL, et al. Biochim Biophys Acta. 2016 Dec;1866(2):221-231. doi: 10.1016/j.bbcan.2016.09.005. Epub 2016 Sep 24. Biochim Biophys Acta. 2016. PMID: 27678419 Free PMC article. Review.
Deciphering the role of nuclear and cytoplasmic IKKα in skin cancer.
Alameda JP, Gaspar M, Ramírez Á, Navarro M, Page A, Suárez-Cabrera C, Fernández MG, Mérida JR, Paramio JM, García-Fernández RA, Fernández-Aceñero MJ, Casanova ML. Alameda JP, et al. Oncotarget. 2016 May 17;7(20):29531-47. doi: 10.18632/oncotarget.8792. Oncotarget. 2016. PMID: 27121058 Free PMC article.
C/EBPbeta modulates the early events of keratinocyte differentiation involving growth arrest and keratin 1 and keratin 10 expression.
Zhu S, Oh HS, Shim M, Sterneck E, Johnson PF, Smart RC. Zhu S, et al. Mol Cell Biol. 1999 Oct;19(10):7181-90. doi: 10.1128/MCB.19.10.7181. Mol Cell Biol. 1999. PMID: 10490653 Free PMC article.
Loss of syndecan-1 is associated with malignant conversion in skin carcinogenesis.
Stepp MA, Pal-Ghosh S, Tadvalkar G, Rajjoub L, Jurjus RA, Gerdes M, Ryscavage A, Cataisson C, Shukla A, Yuspa SH. Stepp MA, et al. Mol Carcinog. 2010 Apr;49(4):363-73. doi: 10.1002/mc.20609. Mol Carcinog. 2010. PMID: 20082322 Free PMC article.
The latest fashions in skin disease.
Carroll JM, Goldsmith LA. Carroll JM, et al. Mol Med. 1995 Jan;1(2):123-6. Mol Med. 1995. PMID: 8529091 Free PMC article. Review.

The suprabasal expression of alpha 6 beta 4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis - PubMed (original) (raw)